InMode Dirección

Dirección controles de criterios 3/4

El CEO de InMode es Moshe Mizrahy, nombrado en Jan 2008, tiene una permanencia de 16.83 años. posee directamente un 2.37% de las acciones de la empresa, con un valor de €37.01M. La antigüedad media del equipo directivo y de la junta directiva es de 16.8 años y 5.3 años, respectivamente.

Información clave

Moshe Mizrahy

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	16.8yrs
Participación del CEO	2.4%
Permanencia media de la dirección	16.8yrs
Promedio de permanencia en la Junta Directiva	5.3yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Moshe Mizrahy en comparación con los beneficios de InMode?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2024	n/a	n/a	US$154m
Jun 30 2024	n/a	n/a	US$149m
Mar 31 2024	n/a	n/a	US$181m
Dec 31 2023	n/a	n/a	US$198m
Sep 30 2023	n/a	n/a	US$180m
Jun 30 2023	n/a	n/a	US$183m
Mar 31 2023	n/a	n/a	US$171m
Dec 31 2022	n/a	n/a	US$162m
Sep 30 2022	n/a	n/a	US$176m
Jun 30 2022	n/a	n/a	US$172m
Mar 31 2022	n/a	n/a	US$169m
Dec 31 2021	n/a	n/a	US$165m
Sep 30 2021	n/a	n/a	US$148m
Jun 30 2021	n/a	n/a	US$128m
Mar 31 2021	n/a	n/a	US$95m
Dec 31 2020	US$216k	US$216k	US$75m
Sep 30 2020	n/a	n/a	US$58m
Jun 30 2020	n/a	n/a	US$50m
Mar 31 2020	n/a	n/a	US$57m
Dec 31 2019	US$216k	US$216k	US$61m

Compensación vs. Mercado: Datos insuficientes para determinar si la compensación total de Moshe es razonable en comparación con empresas de tamaño similar en el mercado German.

Compensación vs. Ingresos: La compensación de Moshe ha sido consistente con los resultados de la empresa en el último año.

CEO

Moshe Mizrahy (71 yo)

16.8yrs

Permanencia

US$216,000

Compensación

Mr. Moshe Mizrahy served as Chairman of Board of Directors of InMode Ltd (Previously Known as InMode Ltd. (formerly known as Invasix Ltd.)) since its inception in January 2008, until July 25, 2024, and ser...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Yair Malca	Chief Financial Officer	7.8yrs	US$1.91m	0.036% € 559.4k
Alon Yaari	Vice President of Operations	no data	US$743.00k	sin datos
Michael Kreindel	CTO & Director	16.8yrs	US$266.00k	3.68% € 57.5m
Nava Tal-Launer	Chief Information Officer	no data	US$321.00k	sin datos
Moshe Mizrahy	CEO & Director	16.8yrs	US$216.00k	2.37% € 37.0m

16.8yrs

Permanencia media

56yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 154 es experimentado (16.8 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Michael Kreindel	CTO & Director	5.3yrs	US$266.00k	3.68% € 57.5m
Moshe Mizrahy	CEO & Director	16.8yrs	US$216.00k	2.37% € 37.0m
Michael Anghel	Independent Chairman	5.3yrs	sin datos	0.0036% € 55.4k
Bruce Mann	Independent Director	5.3yrs	sin datos	0.024% € 374.0k
Hadar Ron	Independent Director	5.3yrs	sin datos	0.068% € 1.1m

5.3yrs

Permanencia media

71yo

Promedio de edad

Junta con experiencia: La junta directiva de 154 se considera experimentada (5.3 años de antigüedad promedio).

InMode Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

InMode Ltd. Announces Executive Departures

InMode Ltd. Announces Executive Departures

InMode Ltd., Annual General Meeting, Apr 01, 2024

Insufficient new directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

Third quarter 2024 earnings released: EPS: US$0.66 (vs US$0.56 in 3Q 2023)

Inmode Ltd. Revises Revenue Guidance for Full Year 2024

InMode Ltd. Announces Executive Departures

InMode Ltd. Announces Executive Departures

Second quarter 2024 earnings released: EPS: US$0.28 (vs US$0.67 in 2Q 2023)

InMode Ltd. Revises Earnings Guidance for the Full Year Ending December 31, 2024

Inmode Introduces Igniterf the Complete Minimally Invasive Soft Tissue Contraction Platform

InMode Ltd. Announces an Additional FDA 510(K) Clearance for the Morpheus8 Technology

InMode Ltd. to Report Q2, 2024 Results on Aug 01, 2024

InMode Ltd. Revises Earnings Guidance for the Full Year Ending December 31, 2024

First quarter 2024 earnings released: EPS: US$0.28 (vs US$0.49 in 1Q 2023)

InMode Ltd. to Report Q1, 2024 Results on May 02, 2024

Inmode Ltd. Provides Revenue Guidance for the First Quarter of 2024

Pomerantz Law Firm Announces the Filing of a Class Action Against Inmode Ltd

Pomerantz Law Firm Announces the Filing of a Class Action Against InMode Ltd

Investor sentiment deteriorates as stock falls 16%

Bragar Eagel & Squire, P.C. Files Class Action Lawsuit Against InMode Ltd

Bragar Eagel & Squire, P.C. Files Class Action Lawsuit Against InMode Ltd

New minor risk - Shareholder dilution

InMode Ltd., Annual General Meeting, Apr 01, 2024

Full year 2023 earnings released: EPS: US$2.37 (vs US$1.96 in FY 2022)

InMode Ltd. to Report Q4, 2023 Results on Feb 13, 2024

InMode Ltd. Provides Revenue Guidance for the Fourth Quarter, Full Year of 2023 and for the Full Year of 2024

Investor sentiment deteriorates as stock falls 15%

InMode Ltd. Revises Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings released: EPS: US$0.56 (vs US$0.59 in 3Q 2022)

InMode Ltd. Revises Revenue Guidance for the Full Year 2023

Investor sentiment deteriorates as stock falls 21%

New major risk - Earnings quality

Second quarter 2023 earnings released: EPS: US$0.67 (vs US$0.54 in 2Q 2022)

InMode Ltd. (NasdaqGS:INMD) acquired Intellectual Property Assets of Viveve Medical Inc.

InMode Ltd. to Report Q2, 2023 Results on Jul 27, 2023

Investor sentiment improves as stock rises 19%

First quarter 2023 earnings released: EPS: US$0.49 (vs US$0.37 in 1Q 2022)

Investor sentiment improves as stock rises 15%

InMode Ltd. Provides Earnings Guidance for the Full Year Ending December 31, 2023

Full year 2022 earnings released: EPS: US$1.96 (vs US$2.03 in FY 2021)

Inmode Ltd. Provides Earnings Guidance for the Fourth Quarter and Full Year 2022 and 2023

InMode Ltd. Receives Health Canada Certification of Forma-I for Dry Eye Disease Due to Meibomian Gland Dysfunction

Insufficient new directors

Third quarter 2022 earnings released: EPS: US$0.59 (vs US$0.54 in 3Q 2021)

InMode Ltd. to Report Q3, 2022 Results on Oct 27, 2022

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: US$0.54 (vs US$0.50 in 2Q 2021)

Investor sentiment improved over the past week

InMode Ltd. Provides Earnings Guidance for the Second Quarter and Full Year of 2022

InMode Ltd. Receives Health Canada Certification of EmpowerRF Women's Wellness Technology

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First quarter 2022 earnings released: EPS: US$0.37 (vs US$0.34 in 1Q 2021)

High number of new and inexperienced directors

InMode Ltd. to Report Q1, 2022 Results on May 02, 2022

High number of new and inexperienced directors

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad